Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Brands Regulatory News (IMB)

Share Price Information for Imperial Brands (IMB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,024.00
Bid: 2,025.00
Ask: 2,026.00
Change: 17.00 (0.85%)
Spread: 1.00 (0.049%)
Open: 2,011.00
High: 2,032.00
Low: 2,009.00
Prev. Close: 2,007.00
IMB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

25 Sep 2018 07:00

RNS Number : 8227B
Imperial Brands PLC
25 September 2018
 

IMPERIAL BRANDS PLC

CAPITAL MARKETS EVENT & PRE-CLOSE TRADING UPDATE

 

25 September 2018

 

Imperial Brands plc will host a capital markets event in London this afternoon focused on the Group's Next Generation Products (NGP) business. Ahead of its close period commencing on 1 October, Imperial Brands is also issuing today the following trading update confirming it is on track to deliver full year constant currency revenue and earnings in line with the guidance range.

 

Building blu: Capital Markets Event

Today's event will provide insights into how we are executing against our NGP strategy. At the heart of our strategy is a desire to create something better for the world's smokers. We want smokers to switch to alternative products with lower health risks. We are enabling this transition by providing an outstanding vaping experience, endorsed by a trusted brand and underpinned by leading edge science.

 

The presentations will set out the considerable potential NGP offers and why this is also additive for Imperial and its shareholders. We will highlight how we are developing the pioneering brand blu with a compelling vaping proposition and a dynamic innovation pipeline to appeal to adult smokers. Our omnichannel approach is building distribution strength across traditional retail outlets, vape stores and online, ensuring our products are available when and where smokers want to buy them.

 

The strong growth in sales of myblu, with an increasing rate of pod repurchase, reflects a really positive response from smokers, vapers and retailers across our current market footprint. Revenues have been gaining momentum this year, resulting in an annualised exit run-rate of around £0.3bn, positioning the Group well for accelerated growth in FY19 and beyond.

 

Our NGP ambitions are reflected in our management incentives to deliver compound annual revenue growth of 35-150% over the three years to FY20. The upper end of this range equates to NGP revenues of around £1.5 billion in FY20. We also have clear levers to drive profitability and expect the NGP business to begin to contribute to Group profit as we exit FY19, with margins continuing to build thereafter.

 

We are also announcing today plans to launch, Pulze, a heated tobacco product early next calendar year.

 

Presentation materials will be posted on our website www.imperialbrandsplc.com.

 

Pre-close Trading Update

Our business is performing well and we remain on track to deliver full year constant currency revenue and earnings growth in line with our guidance range.

 

· NGP is on track with sales of myblu building in key vapour markets

· Stronger second half with improved tobacco price/mix and growing NGP revenues

· Focus on quality growth with continued share gains from Growth Brands

 

As guided at our half year results, our tobacco business is delivering a much stronger second half. Volumes for the full year will outperform the industry, albeit the second half volumes were slightly weaker than the first. This will be more than offset by significantly stronger tobacco price/mix in the second half, which together with increased NGP revenue, will result in revenue growth in line with our guidance range.

 

Our ongoing cost optimisation savings will be slightly above our original expectations of £100 million, while other gains included in adjusted operating profit will be within our expected range of £50m to £100m (2017: £114m).

 

Translation FX at current rate of exchange is expected to impact earnings by c. 3%.

 

The divestment programme we announced in our interim results is on track and progressing well. During the half, we announced the disposal of a further 10% of our holding in Logista SA realising gross proceeds of £235m.

 

The preliminary results for the year ended 30 September 2018 will be announced on 6 November 2018.

 

Segmental Reporting

As our NGP business is becoming a more material part of the Group, we intend to change our segmental reporting for the year ending 30 September 2019. The significant growth potential from NGP, across both our Returns and Growth Markets, means the rationale for our current segmentation is becoming less relevant. Therefore we intend to move to a regional geographic segmentation for future reporting. In addition, all NGP revenue and profit, which is currently reported in our Growth Markets segment, will in future be included within the countries and segments where the sales occur. We will also separately disclose our NGP revenue. Further details, including FY18 comparators on the new basis, will be provided with our full year results.

 

ENDS

 

 

Investor Contacts

Media Contacts

Peter Durman

+44 (0)7970 328 903

Alex Parsons

+44 (0)7967 467 241

Matt Sharff

+44 (0)7964 110 921

Simon Evans

+44 (0)7967 467 684

Mat Slade

+44 (0)7811 974 438

 

Cautionary Statement

Certain statements in this announcement constitute or may constitute forward-looking statements. Any statement in this announcement that is not a statement of historical fact including, without limitation, those regarding the Company's future expectations, operations, financial performance, financial condition and business is or may be a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected or implied in any forward-looking statement. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this announcement. As a result, you are cautioned not to place any reliance on such forward-looking statements. The forward-looking statements reflect knowledge and information available at the date of this announcement and the Company undertakes no obligation to update its view of such risks and uncertainties or to update the forward-looking statements contained herein. Nothing in this announcement should be construed as a profit forecast or profit estimate and no statement in this announcement should be interpreted to mean that the future earnings per share of the Company for current or future financial years will necessarily match or exceed the historical or published earnings per share of the Company. This announcement has been prepared for, and only for the members of the Company, as a body, and no other persons. The Company, its Directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this announcement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGUGDCSXDBGIU
Date   Source Headline
28th Jun 20245:23 pmRNSTransaction in Own Shares
27th Jun 20245:13 pmRNSTransaction in Own Shares
26th Jun 20245:20 pmRNSTransaction in Own Shares
25th Jun 20245:37 pmRNSTransaction in Own Shares
24th Jun 20245:10 pmRNSTransaction in Own Shares
21st Jun 20245:16 pmRNSTransaction in Own Shares
20th Jun 20245:16 pmRNSTransaction in Own Shares
19th Jun 20245:58 pmRNSTransaction in Own Shares
19th Jun 20244:05 pmRNSDirector/PDMR Shareholding
18th Jun 20245:14 pmRNSTransaction in Own Shares
17th Jun 20245:11 pmRNSTransaction in Own Shares
14th Jun 20245:54 pmRNSTransaction in Own Shares
13th Jun 20245:31 pmRNSTransaction in Own Shares
13th Jun 20247:05 amRNSTransaction in Own Shares
11th Jun 20245:58 pmRNSTransaction in Own Shares
10th Jun 20246:14 pmRNSTransaction in Own Shares
7th Jun 20245:39 pmRNSTransaction in Own Shares
6th Jun 20246:01 pmRNSTransaction in Own Shares
6th Jun 20244:48 pmRNSDirector/PDMR Shareholding
4th Jun 20246:13 pmRNSTransaction in Own Shares
3rd Jun 20246:18 pmRNSTransaction in Own Shares
3rd Jun 202410:16 amRNSTotal Voting Rights
31st May 20245:27 pmRNSTransaction in Own Shares
30th May 20245:21 pmRNSTransaction in Own Shares
29th May 20245:17 pmRNSTransaction in Own Shares
28th May 20245:55 pmRNSTransaction in Own Shares
24th May 20245:23 pmRNSTransaction in Own Shares
23rd May 20245:32 pmRNSTransaction in Own Shares
22nd May 20245:04 pmRNSTransaction in Own Shares
21st May 20245:12 pmRNSTransaction in Own Shares
21st May 202410:26 amRNSDirector Declaration
20th May 20245:18 pmRNSTransaction in Own Shares
17th May 20243:15 pmRNSDirector/PDMR Shareholding
15th May 20247:15 amRNSDividend Declaration
15th May 20247:00 amRNSHalf-year Report
14th May 20245:27 pmRNSTransaction in Own Shares
13th May 20245:23 pmRNSTransaction in Own Shares
10th May 20245:32 pmRNSTransaction in Own Shares
9th May 20246:04 pmRNSTransaction in Own Shares
8th May 20245:19 pmRNSTransaction in Own Shares
7th May 20245:27 pmRNSTransaction in Own Shares
3rd May 20245:55 pmRNSTransaction in Own Shares
2nd May 20245:31 pmRNSTransaction in Own Shares
1st May 20245:21 pmRNSTransaction in Own Shares
1st May 202410:17 amRNSTotal Voting Rights
30th Apr 20245:22 pmRNSTransaction in Own Shares
29th Apr 20245:33 pmRNSTransaction in Own Shares
26th Apr 20245:54 pmRNSTransaction in Own Shares
25th Apr 20245:23 pmRNSTransaction in Own Shares
24th Apr 20245:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.